ArticleJournal of clinical microbiology2011
Dried culture spots for Xpert MTB/RIF external quality assessment: results of a phase 1 pilot study in South Africa.
Article in Journal of clinical microbiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.The Cochrane database of systematic reviews · 2014Pooled it
- Construction and application of a heterogeneous quality control library for the Xpert MTB/RIF assay in tuberculosis diagnosis.Frontiers in cellular and infection microbiology · 2023Article
- Advancing proficiency testing for ultra in resource-limited settings using dried tube specimen: A study by SRL-Uganda.PloS one · 2023Article
- Flow cytometry method for absolute counting and single-cell phenotyping of mycobacteria.Scientific reports · 2021Article
- National Proficiency Testing of Molecular Diagnostics for Tuberculosis and Drug Resistance Detection - China, 2014-2019.China CDC weekly · 2021Article
- The Development of a Standardized Quality Assessment Material to Support XpertDiagnostics (Basel, Switzerland) · 2021Article
- Performance of the Roche cobas MTB Assay for the Molecular Diagnosis of Pulmonary Tuberculosis in a High HIV Burden Setting.The Journal of molecular diagnostics : JMD · 2020Article
- A global proficiency testing programme for Xpert® MTB/RIF using dried tube specimens, 2013-2015.African journal of laboratory medicine · 2020Article
- Development of dried tube specimens for Xpert MTB/RIF proficiency testing.African journal of laboratory medicine · 2020Article
- Performance and workflow assessment of six nucleic acid extraction technologies for use in resource limited settings.PloS one · 2019Article
- Genetic Mimetics of Mycobacterium tuberculosis and Methicillin-Resistant Staphylococcus aureus as Verification Standards for Molecular Diagnostics.Journal of clinical microbiology · 2017Article
- Rolling Out XpertAfrican journal of laboratory medicine · 2017Article
- Impact of the GeneXpert MTB/RIF Technology on Tuberculosis Control.Microbiology spectrum · 2017Review
- The use of digital PCR to improve the application of quantitative molecular diagnostic methods for tuberculosis.BMC infectious diseases · 2016Article
- Options to Expand HIV Viral Load Testing in South Africa: Evaluation of the GeneXpert® HIV-1 Viral Load Assay.PloS one · 2016Article
- South Africa's experience with provision of quality HIV diagnostic services.African journal of laboratory medicine · 2016Article
- A pilot evaluation of external quality assessment of GenoType MTBDRplus versions 1 and 2 using dried culture spot material.Journal of clinical microbiology · 2015Article
- Evaluation of the Cepheid Xpert MTB/RIF assay.Expert review of molecular diagnostics · 2015Review
- Feasibility of HIV point-of-care tests for resource-limited settings: challenges and solutions.BMC medicine · 2014Article
- Multicenter feasibility study to assess external quality assessment panels for Xpert MTB/RIF assay in South Africa.Journal of clinical microbiology · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Implementation of Xpert MTB/RIF requires quality assessment. A pilot program using dried culture spots (DCSs) of inactivated Mycobacterium tuberculosis is described. Of 274 DCS results received, 2.19% generated errors; the remainder yielded 100% correct Mycobacterium tuberculosis detection. The probe A cycle threshold (C(T)) variability of three DCS batches was ≤ 3.47. The study of longer-term DCS stability is ongoing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.